Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999
Top Cited Papers
- 1 January 2001
- journal article
- other
- Published by Springer Nature in Drug Information Journal
- Vol. 35 (1) , 293-317
- https://doi.org/10.1177/009286150103500134
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Effect of Regulatory Withdrawal of Drugs and Prescription Recommendations on the Pattern of Self-poisonings in OsloActa Medica Scandinavica, 2009
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- ThalidomideDrug Safety, 1995
- Idiosyncratic Drug-Induced Haematological AbnormalitiesDrug Safety, 1994
- Postmarketing Surveillance of Quinolones, 1990 to 1992Drugs, 1993
- Contraceptive choices — turning back the clockAdvances in Contraception, 1991
- When is a drug 'safe'?Nature, 1990
- Safety Considerations in Product DevelopmentDrug Safety, 1990
- Comparison of the Safety of Several Nonsteroidal Anti‐inflammatory Drugs Currently or Formerly Marketed in the United KingdomThe Journal of Clinical Pharmacology, 1988
- Drug innovation—what's slowing it down?Nature, 1980